Capnia, Inc. (SLNO) Upgraded at ValuEngine

ValuEngine upgraded shares of Capnia, Inc. (NASDAQ:SLNO) from a strong sell rating to a sell rating in a report published on Friday.

Separately, Maxim Group restated a buy rating and set a $25.00 target price on shares of Capnia in a research report on Wednesday, September 13th.

Capnia (SLNO) opened at 2.44 on Friday. The stock has a 50 day moving average price of $0.59 and a 200 day moving average price of $0.59. The stock’s market capitalization is $23.39 million. Capnia has a 12 month low of $0.49 and a 12 month high of $6.60.

Capnia (NASDAQ:SLNO) last posted its earnings results on Friday, August 11th. The company reported ($0.30) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.40) by $0.10. Capnia had a negative return on equity of 69.67% and a negative net margin of 1,389.76%. Equities analysts predict that Capnia will post ($0.27) EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Capnia, Inc. (SLNO) Upgraded at ValuEngine” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://ledgergazette.com/2017/10/09/capnia-inc-slno-upgraded-at-valuengine.html.

About Capnia

Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

To view ValuEngine’s full report, visit

Separately, Maxim Group restated a buy rating and set a $25.00 target price on shares of Capnia in a research report on Wednesday, September 13th.

Capnia (SLNO) opened at 2.44 on Friday. The stock has a 50 day moving average price of $0.59 and a 200 day moving average price of $0.59. The stock’s market capitalization is $23.39 million. Capnia has a 12 month low of $0.49 and a 12 month high of $6.60.

Capnia (NASDAQ:SLNO) last posted its earnings results on Friday, August 11th. The company reported ($0.30) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.40) by $0.10. Capnia had a negative return on equity of 69.67% and a negative net margin of 1,389.76%. Equities analysts predict that Capnia will post ($0.27) EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Capnia, Inc. (SLNO) Upgraded at ValuEngine” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://ledgergazette.com/2017/10/09/capnia-inc-slno-upgraded-at-valuengine.html.

About Capnia

Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply